Maud Racape
Overview
Explore the profile of Maud Racape including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loupy A, Certain A, Tangprasertchai N, Racape M, Ursule-Dufait C, Benbadi K, et al.
Transpl Int
. 2025 Jan;
37:13919.
PMID: 39741495
Donor-derived cell-free DNA (dd-cfDNA) is an emerging non-invasive biomarker for allograft injury detection. This study aimed to evaluate a new, decentralized dd-cfDNA testing kit against a centralized dd-cfDNA testing service...
2.
Cortes Garcia E, Giarraputo A, Racape M, Goutaudier V, Ursule-Dufait C, De La Grange P, et al.
Transplantation
. 2024 Oct;
PMID: 39441708
Background: In kidney transplantation, molecular diagnostics may be a valuable approach to improve the precision of the diagnosis. Using next-generation sequencing (NGS), we aimed to identify clinically relevant archetypes. Methods:...
3.
Goutaudier V, Danger R, Catar R, Racape M, Philippe A, Elias M, et al.
Kidney Int
. 2024 Aug;
106(5):943-960.
PMID: 39197587
Non-invasive biomarkers are promising tools for improving kidney allograft rejection monitoring, but their clinical adoption requires more evidence in specifically designed studies. To address this unmet need, we designed the...
4.
Cortes Garcia E, Giarraputo A, Racape M, Goutaudier V, Ursule-Dufait C, De La Grange P, et al.
Transpl Int
. 2024 Jul;
37:13043.
PMID: 39050190
Recently, interest in transcriptomic assessment of kidney biopsies has been growing. This study investigates the use of NGS to identify gene expression changes and analyse the pathways involved in rejection....
5.
Aubert O, Ursule-Dufait C, Brousse R, Gueguen J, Racape M, Raynaud M, et al.
Nat Med
. 2024 Jun;
30(8):2320-2327.
PMID: 38824959
Donor-derived cell-free DNA (dd-cfDNA) is an emerging noninvasive biomarker that has the potential to detect allograft injury. The capacity of dd-cfDNA to detect kidney allograft rejection and its added clinical...
6.
Goutaudier V, Sablik M, Racape M, Rousseau O, Audry B, Kamar N, et al.
Eur J Epidemiol
. 2024 Apr;
39(5):549-564.
PMID: 38625480
There is an unmet need for robust and clinically validated biomarkers of kidney allograft rejection. Here we present the KTD-Innov study (ClinicalTrials.gov, NCT03582436), an unselected deeply phenotyped cohort of kidney...
7.
Coutance G, Racape M, Baudry G, Lecuyer L, Roubille F, Blanchart K, et al.
J Heart Lung Transplant
. 2023 Jul;
42(11):1505-1509.
PMID: 37487804
While studies have shown an association between microRNAs and cardiac rejection, the clinical relevance of a preidentified miRNA signature as a noninvasive biomarker has never been assessed in prospective multicentric...
8.
Coutance G, Zouhry I, Racape M, Drieux F, Viailly P, Rouvier P, et al.
Transplantation
. 2021 Dec;
106(7):1455-1464.
PMID: 34954735
Background: The pathology-based diagnosis of cardiac antibody-mediated rejection (AMR) relies on the 2013 International Society for Heart and Lung Transplantation Working Formulation, in which microvascular inflammation (MVI) is considered as...
9.
Loupy A, Coutance G, Bonnet G, Van Keer J, Raynaud M, Aubert O, et al.
Circulation
. 2020 May;
141(24):1954-1967.
PMID: 32363949
Background: Cardiac allograft vasculopathy (CAV) is a major contributor of heart transplant recipient mortality. Little is known about the prototypes of CAV trajectories at the population level. We aimed to...
10.
Koenig A, Chen C, Marcais A, Barba T, Mathias V, Sicard A, et al.
Nat Commun
. 2019 Nov;
10(1):5350.
PMID: 31767837
Current doctrine is that microvascular inflammation (MVI) triggered by a transplant -recipient antibody response against alloantigens (antibody-mediated rejection) is the main cause of graft failure. Here, we show that histological...